Navigation Links
BioNeutral's Ygiene(TM) Achieves World's Fastest Kill Time With a 100% Total Spore Eradication Verified In Independent Sporicidal/Sterilant Test
Date:8/12/2009

NEWARK, N.J., Aug. 12 /PRNewswire-FirstCall/ -- BioNeutral Group, Inc. ("BioNeutral") (OTC Bulletin Board: BONU), a specialty chemical technology-based Life Science company announced today that ATS Labs using the EPA required AOAC Sporicidal Test with Ygiene(TM) Hospital Grade formula delivered a 100% Total Kill of over one million live Clostridium Sporogenes spores in a four (4) minute time frame - performance which is up to 75 times faster than competitive products such as Steris(R) Spor-Klenz RTU.

"The company is in discussions with a global leader in the health care sector to arrange distribution following our regulatory approval," said Stephen J. Browand, CEO BioNeutral Group Inc. "Our health care market alone is very broad and includes every hospital, nursing home, home health care patient, every immune suppressed patient, emergency room, ambulance, first responder, and doctor, dental, and veterinary office."

"Whether it is the present Swine Flu (H1N1) pandemic or the most difficult to kill dangerous organisms, Bioneutral's technology has given rise to the only family of sporicidal formulations for the hospital/health care sector, industry (including schools) and the home. Performance is unsurpassed, it has a Green environmental profile, is non corrosive, non staining to most fabrics (eg sheets and pillow cases) and can come into contact with skin while remaining sporicidal," said Dr Andy Kielbania PhD, BioNeutral's Chief Scientific Officer.

This EPA required AOAC Sporicidal Test utilizing spore impregnated knotted suture loops is an extremely difficult test to pass especially when starting with over one million Clostridium Sporogenes spores. The rapid elimination of these health threatening microorganisms at health care facilities will reduce the incidents of Hospital Acquired Infections (ACI) and the associated loss of lives. Many of today's best known industrial disinfectants, including those commonly used in hospitals and health care facilities, are unable to pass this test at all or require up to several hours of direct wet contact to pass.

Examples of commonly used antimicrobials in health care facilities which cannot claim passing this EPA sporicide/sterilant test include CaviCide(R) and Medica DC 10(TM). While these antimicrobials may eliminate easily eradicated bacteria and some viruses, they have no effect on spores and therefore cannot claim to be sporicidal. Examples of antimicrobials which have passed the EPA required test include Actril(R) Cold Sterilant and Clidox(R)(R)-S which require hours to be effective. Steris(R) Hydrogen Peroxide Sterilant requires special protective equipment and highly trained professionals to correctly apply this antimicrobial. In addition this product requires 90 minutes of direct contact to eliminate spores. Steris(R) Spor-Klenz RTU is easier to apply but can take up to five and one half hours (5.5 hours) to eliminate spores.

A sporicide/sterilant which operates at room temperature with the rapid kill demonstrated by Ygiene(TM) Hospital Grade will provide a substantial economic advantage for future users. Ygiene is easy to use and provides a much quicker turn around time for total sterilization of equipment and facilities. BioNeutral's Ygiene(TM) will reduce the cost of human resources and capital expenditure, decrease turnaround time for surgical procedures and medical facilities thereby maximizing precious resources while providing increased safety for staff and patients alike.

About ATS Labs:

ATS Labs, http://www.ats-labs.com is a leading internationally recognized lab used by the developers and users of antimicrobial products. They provide comprehensive antimicrobial service and their superior client service and scientific data have earned them a distinguished record of acceptance with regulatory agencies in the U.S., Canada and the world.

About BioNeutral Group, Inc.

Headquartered at the New Jersey Institute of Technology/EDC in Newark, New Jersey, BioNeutral Group, Inc., is a chemical technology-based Life Science company that intends to commercialize a combinational chemistry-based technology which can neutralize harmful environmental contaminants, toxins and dangerous micro-organisms including bacteria, viruses, mold, fungi and spores. The formulations, including Ygiene(TM) and Ogiene(TM), which are eco-friendly and include natural and common ingredients which are found in baby products and in every day foods. The Company has combined these widely-used compounds in highly specialized ways to create products that dramatically enhance disinfecting and cleaning results; products include BioNeutralizers and ChemoNeutralizers. BioNeutral's proprietary platform technology has been proven effective in surface, water and airborne applications.

More information about the Company may be found at www.bioneutralgroup.com

Forward-Looking Statements

BioNeutral routinely tests its formulations against those of its competitors. The results are published to let shareholders know how the Company's technology compares with known formulations in the market place. Any product claim for antimicrobial activity requires approval from the EPA or FDA, depending upon where and how the formulations are used. The EPA and FDA have not reviewed or confirmed the Company's data and findings. BioNeutral's antimicrobial formulations will be marketed under the brand name Ygiene(TM) and are not yet available for sale in the United States.

Contact Information

    BioNeutral Group Inc.
    Stephen J. Browand, President and CEO
    steve@bioneutralgroup.com

    Investor Relations
    Aimee Boutcher
    973 239-2878
    aboutcher@aol.com


'/>"/>
SOURCE BioNeutral Group, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Independent Laboratory Testing Shows BioNeutrals Hospital Grade Ygiene(TM) Eliminates Aspergillus Niger (Black Mold) Spores
2. Kingfisher Healthcare (KFH) Achieves World Class Quality Platform
3. Kaiser Permanente Achieves Climate Action Leader Status
4. OSF HealthCare Achieves Impressive Tobacco Quit Rates with the Free & Clear(R) Quit For Life(TM) Program
5. LMS integrated obstetrics solution achieves general availability
6. ENDEAVOR IV achieves primary endpoint, demonstrates similar safety profile compared to Taxus stent
7. Pharsight Achieves $7.3 Million in Quarterly Revenue
8. Halogen Software Achieves Most Successful Quarter in Company History - Includes Record Year-Over-Year Overall and License Revenue
9. Cethromycin achieves all endpoints in second pivotal Phase III Trial for treatment for pneumonia
10. Joint Commission International Achieves Accreditation from ISQua
11. TyraTech Achieves Insecticide Development and Financial Milestones With Partner Arysta LifeScience
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/19/2017)... Charleston, South Carolina (PRWEB) , ... February 19, 2017 , ... ... class of evening undergraduate nursing students, is being led by Amelia Joseph, Ph.D. Joseph ... direct the initial operations of the nursing department in early 2016. After a nation-wide ...
(Date:2/19/2017)... (PRWEB) , ... February 19, 2017 , ... ProBrand Glitch is a set of 30 ... ProBrand Glitch users can easily reveal any logo with a glitch reveal in just a ... control over the style and animation of each preset. Use these presets to add a ...
(Date:2/19/2017)... ... February 19, 2017 , ... ... healthcare, will join forces with Healthwise ® at HIMSS 2017 ... industry leader in evidence-based health education, technology and services, will demonstrate a voice-powered ...
(Date:2/18/2017)... ... February 17, 2017 , ... Focused start-ups, not ... the industry, according to the recent NEJM Catalyst Insights Report on the New ... NEJM Catalyst Insights Council, a qualified group of U.S. executives, clinical leaders, and ...
(Date:2/18/2017)... ... February 17, 2017 , ... ... drvallecillos.com , Beverly Hills plastic surgeon Dr. Glenn Vallecillos experiments ... Dr. Vallecillos says, "Traditionally, plastic surgery has been centered around that idea that ...
Breaking Medicine News(10 mins):
(Date:2/20/2017)... 21, 2017 Taiwan Biophotonic Co. (tBPC), a ... vital signs sensing solutions, today announced the CE Marking ... pulse oximeter, the oCare TM Pro 100, which is ... medical devices space.  tBPC,s Wrist Pulse Oximeter, ... simple and reliable method to measure and record heart ...
(Date:2/20/2017)... , Feb. 20, 2017 Provides understanding ... agreements entered into by the worlds leading healthcare ... Description The Global Anemia Partnering Terms ... access to partnering deals and agreements entered into ... - Trends in partnering deals - Top ...
(Date:2/20/2017)... , Feb. 20, 2017  This Report analyzes the worldwide ... Dosage Forms: Injectables, Solid Dosage Forms, and Liquid & Semi-solid Dosage ... Canada , Japan , ... World. Read the full report: http://www.reportlinker.com/p04707109-summary/view-report.html ... Annual estimates ...
Breaking Medicine Technology: